Johnson Lau | Chief Executive Officer |
Caileigh Dougherty | Investor Relations |
Dan Lang | President, Athenex Cell Therapy |
Kurt Gunter | Chief Medical Officer, Cell Therapy and Head, Regulatory Affairs |
Jeff Yordon | Chief Operating Officer |
Joe Annoni | Chief Financial Officer |
Jonathan Miller | Evercore ISI |
Kevin DeGeeter | Oppenheimer |
Kennen MacKay | RBC Capital Markets |
Matt Kaplan | Ladenburg Thalmann |
Yale Jen | Laidlaw & Company |
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2021 Athenex Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Caileigh Dougherty, Director of Investor Relations.